Analysis of Novel Immunological Biomarkers Related to Rheumatoid Arthritis Disease Severity
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241512351 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Sandra Pascual-García und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, University of Alicante, 03690 San Vicente del Raspeig, Spain. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Biomarkers. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish Ministry of Education, University of Alicante, Spanish Ministry of Education, Culture, and Sport.
Abstract (Originalsprache)
Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) are the most frequently used rheumatoid arthritis (RA) diagnostic markers, but they are unable to anticipate the patient’s evolution or response to treatment. The aim of this study was to identify possible severity biomarkers to predict an upcoming flare-up or remission period. To address this objective, sera and anticoagulated blood samples were collected from healthy controls (HCs; n = 39) and from early RA (n = 10), flare-up (n = 5), and remission (n = 16) patients. We analyzed leukocyte phenotype markers, regulatory T cells, cell proliferation, and cytokine profiles. Flare-up patients showed increased percentages of cluster of differentiation (CD)3+CD4− lymphocytes (p < 0.01) and granulocytes (p < 0.05) but a decreased natural killer (NK)/T lymphocyte ratio (p < 0.05). Analysis of leukocyte markers by principal component analysis (PCA) and receiver operating characteristic (ROC) curves showed that CD45RO+ (p < 0.0001) and CD45RA+ (p < 0.0001) B lymphocyte expression can discriminate between HCs and early RA patients, while CD3+CD4− lymphocyte percentage (p < 0.0424) and CD45RA+ (p < 0.0424), CD62L+ (p < 0.0284), and CD11a+ (p < 0.0185) B lymphocyte expression can differentiate between flare-up and RA remission subjects. Thus, the combined study of these leukocyte surface markers could have potential as disease severity biomarkers for RA, whose fluctuations could be related to the development of the characteristic pro-inflammatory environment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, University of Alicante, 03690 San Vicente del Raspeig, Spain.
- Rheumatology Unit, University General Hospital of Elche, 03203 Elche, Spain.
- Medical Oncology Department, Dr. Balmis University General Hospital, Pintor Baeza 12, 03010 Alicante, Spain.
- Alicante Institute for Health and Biomedical Research (ISABIAL), Pintor Baeza 12, 03010 Alicante, Spain.
- Biochemistry and Cell Therapy Unit, Institute of Bioengineering, Miguel Hernandez University of Elche, 03202 Elche, Spain.
- Pathology Department, Dr. Balmis University General Hospital, Pintor Baeza 12, 03010 Alicante, Spain.
ORCID-Profile: Sandra Pascual-García, Pascual Martínez-Peinado, Yoel G Montoyo-Pujol, Enrique Roche
Förderung
- Spanish Ministry of Education
- University of Alicante
- Spanish Ministry of Education, Culture, and Sport
- Office of the Vice President of Research and Knowledge Transfer
Zitieren
APA
Pascual-García, S., Martínez-Peinado, P., López-Jaén, A. B., Navarro-Blasco, F. J., Montoyo-Pujol, Y. G., Roche, E., Peiró, G., & Sempere-Ortells, J. M. (2023). Analysis of Novel Immunological Biomarkers Related to Rheumatoid Arthritis Disease Severity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512351
Vancouver
Pascual-García S, Martínez-Peinado P, López-Jaén AB, Navarro-Blasco FJ, Montoyo-Pujol YG, Roche E, et al. Analysis of Novel Immunological Biomarkers Related to Rheumatoid Arthritis Disease Severity. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512351
BibTeX
@article{PascualGarca2023,
author = {Pascual-García, Sandra and Martínez-Peinado, Pascual and López-Jaén, Ana B and Navarro-Blasco, Francisco J and Montoyo-Pujol, Yoel G and Roche, Enrique and Peiró, Gloria and Sempere-Ortells, José M},
title = {Analysis of Novel Immunological Biomarkers Related to Rheumatoid Arthritis Disease Severity},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241512351}
}
EUVIMED